Pulmonx (LUNG) Operating Leases (2019 - 2025)

Pulmonx (LUNG) has 7 years of Operating Leases data on file, last reported at $18.1 million in Q4 2025.

• Operating Leases for Q4 2025 came in at $18.1 million, down 2.46% year-over-year; the trailing twelve-month figure through Dec 2025 was $18.1 million (down 2.46% YoY), and the FY2025 annual result was $18.1 million, down 2.46% from the prior year.
• Operating Leases declined to $18.1 million in Q4 2025 per LUNG's latest filing, from $19.4 million in the prior quarter.
• Over five years, Operating Leases peaked at $19.4 million in Q3 2025 and troughed at $1.1 million in Q4 2023.
• A 5-year average of $10.0 million and a median of $7.5 million in 2021 frame the typical range for Operating Leases.
• The sharpest annual moves came in 2023 and 2024: Operating Leases sank 71.27% in 2023, then surged 1574.05% in 2024.
• A 5-year view of Operating Leases shows it stood at $6.8 million in 2021, then sank by 43.76% to $3.8 million in 2022, then slumped by 71.27% to $1.1 million in 2023, then surged by 1574.05% to $18.5 million in 2024, then declined by 2.46% to $18.1 million in 2025.
• Business Quant data shows LUNG's Operating Leases at $18.1 million in Q4 2025, $19.4 million in Q3 2025, and $18.6 million in Q2 2025.